The Beauty Health Company (NASDAQ: SKIN) reported Q3 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $78.8 million versus the consensus estimate of $73.8 million.

GUIDANCE:

The Beauty Health Company sees FY2024 revenue of $322-332 million, versus the consensus of $341.1 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.